R

Redhill Biopharma Ltd
D

RDHL

0.48570
USD
-0.01
(-2.47%)
مفتوح الان
حجم التداول
4,453
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,355,854
أصول ذات صلة المقالات
المزيد

العنوان: Redhill Biopharma Ltd

القطاع: الرعاية الصحية
الصناعة: Drug Manufacturers - Specialty & Generic
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.